dc.contributor.author |
Gilling, Peter |
en |
dc.contributor.author |
Nickel, JC |
en |
dc.contributor.author |
Tammela, TL |
en |
dc.contributor.author |
Morrill, B |
en |
dc.contributor.author |
Wilson, TH |
en |
dc.contributor.author |
Wilson, TH |
en |
dc.contributor.author |
Rittmaster, RS |
en |
dc.date.accessioned |
2012-03-21T00:18:22Z |
en |
dc.date.issued |
2011 |
en |
dc.identifier.citation |
British Journal of Urology (BJU) International 108(3):388-394 2011 |
en |
dc.identifier.issn |
1464-4096 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/14796 |
en |
dc.description.abstract |
OBJECTIVE • To assess the efficacy and safety of dutasteride compared with finasteride in treating men with symptomatic benign prostatic hyperplasia (BPH) for 12 months. |
en |
dc.publisher |
the authors; British Journal of Urology |
en |
dc.relation.ispartofseries |
BJU International |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.title |
Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS). |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1111/j.1464-410X.2011.10195.x |
en |
pubs.issue |
3 |
en |
pubs.begin-page |
388 |
en |
pubs.volume |
108 |
en |
dc.rights.holder |
Copyright: the authors; British Journal of Urology |
en |
dc.identifier.pmid |
21631695 |
en |
pubs.end-page |
394 |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Article |
en |
pubs.elements-id |
314701 |
en |
dc.identifier.eissn |
1464-410X |
en |
pubs.record-created-at-source-date |
2012-03-09 |
en |
pubs.dimensions-id |
21631695 |
en |